Skip to main content
Premium Trial:

Request an Annual Quote

Tempus Gains FDA Premarket Approval for NGS Solid Tumor Profiling Test

NEW YORK – Tempus said Monday that the US Food and Drug Administration has given premarket approval for the firm's companion diagnostic test for colorectal cancer treatment.

Chicago-based Tempus' xT CDx is a 648-gene next-generation sequencing test that can be used to provide solid tumor profiling in cancer patients with solid malignant neoplasms. It detects single- and multi-nucleotide variants, insertions, and deletions and microsatellite instability status from formalin-fixed, paraffin-embedded tumor tissue specimens and DNA isolated from matched normal blood or saliva specimens.

The test is intended as a companion diagnostic that could help identify which patients would benefit from treatment with targeted therapies. It is performed at Tempus' facility in Chicago.

Tempus CEO Eric Lefkofsky said in a statement that the premarket approval is a significant milestone for the company as it tries to establish a regulatory pathway for its testing platform, "which offers solutions to advance both clinical care and support cutting-edge research. We designed xT CDx to be a smart test that can empower physicians to provide personalized care for their patients and support researchers in developing better therapeutics," he said.

The Scan

ChatGPT Does As Well As Humans Answering Genetics Questions, Study Finds

Researchers in the European Journal of Human Genetics had ChatGPT answer genetics-related questions, finding it was about 68 percent accurate, but sometimes gave different answers to the same question.

Sequencing Analysis Examines Gene Regulatory Networks of Honeybee Soldier, Forager Brains

Researchers in Nature Ecology & Evolution find gene regulatory network differences between soldiers and foragers, suggesting bees can take on either role.

Analysis of Ashkenazi Jewish Cohort Uncovers New Genetic Loci Linked to Alzheimer's Disease

The study in Alzheimer's & Dementia highlighted known genes, but also novel ones with biological ties to Alzheimer's disease.

Tara Pacific Expedition Project Team Finds High Diversity Within Coral Reef Microbiome

In papers appearing in Nature Communications and elsewhere, the team reports on findings from the two-year excursion examining coral reefs.